Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Hippocratic AI Accelerates Team Growth and Key Executive Hires

businesswire.com
NVDA NVIDIA is mentioned as a backer of Hippocratic AI through its investment arm, NVentures, indicating a positive association with a growing company in the AI healthcare space. GOOG Alphabet Inc. is mentioned as an investor in Hippocratic AI through its investment arm, CapitalG, suggesting a positive outlook on the company's growth and potential.

PALO ALTO, Calif.--( BUSINESS WIRE)--Hippocratic AI, global leader and pioneer of generative AI healthcare agents, announced today that it has more than doubled the size of its team in the past year, and is expanding its executive leadership team with the addition of industry veterans across key functions. These strategic hires position the company to meet rising demand across providers, payors, government, and life sciences sectors, while advancing its mission to deliver healthcare abundance through scalable, patient-facing generative AI. The growth also strengthens the company’s ability to support its expanding partner network with the operational depth, clinical insight, and responsiveness needed to ensure successful deployment and long-term value. Hippocratic AI earlier this month raised its Series C funding and has surpassed 115 million patient interactions.

“We’re experiencing extraordinary momentum as health systems, payors, and life sciences organizations embrace safe generative AI agents to close critical care gaps and provide healthcare abundance,” said Munjal Shah, CEO and Co-founder of Hippocratic AI. “We welcome this world-class group of executives who bring deep expertise in healthcare, go-to-market strategy, and operations. Their leadership helps us scale responsibly while setting the standard for safe, effective generative AI in healthcare.”

New Executive Appointments:

This expanded company growth and leadership team ensures the company remains equipped to deliver enterprise-grade solutions rooted in clinical safety, patient trust, and measurable patient impact.

About Hippocratic AI

Hippocratic AI has developed the safest generative AI Agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.